{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:09:13Z","timestamp":1781323753369,"version":"3.54.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010733","name":"Child Cancer Foundation","doi-asserted-by":"publisher","award":["2021-7439"],"award-info":[{"award-number":["2021-7439"]}],"id":[{"id":"10.13039\/100010733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010128","name":"Lasten Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6 V\u00e4reen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016412","name":"Mary Beves Foundation for Childhood Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Childhood Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008488","name":"Alma and KA Snellman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.thromres.2025.109287","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T14:17:33Z","timestamp":1740061053000},"page":"109287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Venous thromboembolism in children with Hodgkin lymphoma \u2013 A population-based study in Sweden, Finland, and Denmark"],"prefix":"10.1016","volume":"248","author":[{"given":"Mia","family":"Giertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Aarnivala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha W.","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bj\u00f6rklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Gr\u00f6nroos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa L.","family":"Hjalgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Huttunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Niinim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuuli","family":"P\u00f6yh\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Raittinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Ranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan E.","family":"Svahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"T\u00f6rnudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arja","family":"Harila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2025.109287_bb0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.thromres.2013.12.021","article-title":"Venous thromboembolism in children with cancer - a population-based cohort study","volume":"133","author":"Walker","year":"2014","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.thromres.2025.109287_bb0010","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/annonc\/mdz168","article-title":"Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials","volume":"30","author":"Borchmann","year":"2019","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109287_bb0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mpd.2001.118192","article-title":"Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands","volume":"139","author":"van Ommen","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.thromres.2025.109287_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fped.2017.00012","article-title":"Venous thromboembolism in children with cancer and blood disorders","volume":"5","author":"Ko","year":"2017","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.thromres.2025.109287_bb0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.thromres.2017.02.011","article-title":"Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden","volume":"152","author":"Schonning","year":"2017","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2025.109287_bb0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.thromres.2007.12.006","article-title":"Thromboembolism in children with lymphoma","volume":"122","author":"Athale","year":"2008","journal-title":"Thromb. Res."},{"issue":"43","key":"10.1016\/j.thromres.2025.109287_bb0035","first-page":"3424","article-title":"Venous thromboembolism in children","volume":"170","author":"Tuckuviene","year":"2008","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.thromres.2025.109287_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","article-title":"Mechanisms and risk factors of thrombosis in cancer","volume":"118","author":"Falanga","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"11","key":"10.1016\/j.thromres.2025.109287_bb0045","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.thromres.2025.109287_bb0050","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.clml.2020.02.021","article-title":"The incidence of venous thromboembolism and impact on survival in Hodgkin lymphoma","volume":"20","author":"Kirkizlar","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"7","key":"10.1016\/j.thromres.2025.109287_bb0055","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood-2014-04-570531","article-title":"Postthrombotic syndrome following upper extremity deep vein thrombosis in children","volume":"124","author":"Avila","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2025.109287_bb0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1538-7836.2008.02901.x","article-title":"Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia","volume":"6","author":"Kuhle","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/pbc.25302","article-title":"Post-thrombotic syndrome after central venous catheter removal in childhood cancer survivors: a prospective cohort study","volume":"62","author":"Polen","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0070","first-page":"83","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"16","key":"10.1016\/j.thromres.2025.109287_bb0075","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/cncr.28748","article-title":"Declining childhood and adolescent cancer mortality","volume":"120","author":"Smith","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28057","article-title":"The association of mediastinal mass in the formation of thrombi in pediatric patients with non-lymphoblastic lymphomas","volume":"67","author":"Gartrell","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2025.109287_bb0085","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jth.13913","article-title":"Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues","volume":"16","author":"Newall","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"22","key":"10.1016\/j.thromres.2025.109287_bb0095","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","article-title":"American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","volume":"2","author":"Monagle","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2025.109287_bb0100","article-title":"Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters","volume":"no. 9","author":"Schoot","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.thromres.2025.109287_bb0115","unstructured":"\u201cEliquis, INN-apixaban - European Medicines Agency, SUMMARY OF PRODUCT CHARACTERISTICS.\u201d."},{"key":"10.1016\/j.thromres.2025.109287_bb0120","unstructured":"\u201cDabigatran Etexilate Accord - European Medicines Agency, SUMMARY OF PRODUCT CHARACTERISTICS.\u201d."},{"issue":"7","key":"10.1016\/j.thromres.2025.109287_bb0125","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.thromres.2025.109287_bb0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.2047-6310.2012.00064.x","article-title":"Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity","volume":"7","author":"Cole","year":"2012","journal-title":"Pediatr. Obes."},{"issue":"6","key":"10.1016\/j.thromres.2025.109287_bb0135","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/17477161003615583","article-title":"Defining obesity risk status in the general childhood population: which cut-offs should we use?","volume":"5","author":"de Onis","year":"2010","journal-title":"Int. J. Pediatr. Obes."},{"issue":"11","key":"10.1016\/j.thromres.2025.109287_bb0140","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/0091270003258651","article-title":"Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics","volume":"43","author":"Mager","year":"2003","journal-title":"J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.thromres.2025.109287_bb0145","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109287_bb0150","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2025.109287_bb0155","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00277-018-3371-0","article-title":"The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study","volume":"97","author":"Forbrigger","year":"2018","journal-title":"Ann. Hematol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109287_bb0160","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1160\/TH13-10-0827","article-title":"Epidemiology of venous thrombosis in children with cancer","volume":"111","author":"Piovesan","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2025.109287_bb0165","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1007\/PL00014341","article-title":"Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters","volume":"158","author":"Wermes","year":"1999","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30096","article-title":"Pediatric cancer-associated thrombosis: analysis from a tertiary care cancer center in India","volume":"70","author":"Dhariwal","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"issue":"5","key":"10.1016\/j.thromres.2025.109287_bb0175","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jpeds.2013.06.076","article-title":"Port-a-cath-related thrombosis and postthrombotic syndrome in pediatric oncology patients","volume":"163","author":"Albisetti","year":"2013","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.thromres.2025.109287_bb0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/jth.13236","article-title":"Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study","volume":"14","author":"Tuckuviene","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0185","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V83.2.386.386","article-title":"Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L\u2019Asparaginase-induced antithrombin III deficiency","volume":"83","author":"Mitchell","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0190","first-page":"120","article-title":"Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia","volume":"16","author":"Mitchell","year":"1994","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0195","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1055\/s-0039-1688412","article-title":"Venous thrombosis in children with acute lymphoblastic leukemia treated on DCOG ALL-9 and ALL-10 protocols: the effect of fresh frozen plasma","volume":"3","author":"Klaassen","year":"2019","journal-title":"TH Open"},{"issue":"1","key":"10.1016\/j.thromres.2025.109287_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28040","article-title":"Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia","volume":"67","author":"Finch","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.thromres.2025.109287_bb0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2003.10.013","article-title":"Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia","volume":"111","author":"Athale","year":"2003","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.thromres.2025.109287_bb0210","first-page":"8069","article-title":"Central venous catheter-associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice","volume":"30","author":"van den Bosch","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.thromres.2025.109287_bb0215","first-page":"1","article-title":"Characterizing age-related differences in Hodgkin lymphoma in children, adolescents and young adults","author":"Kendel","year":"2024","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109287_bb0220","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.thromres.2012.03.019","article-title":"Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population","volume":"130","author":"Park","year":"2012","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.thromres.2025.109287_bb0225","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.thromres.2025.109287_bb0230","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/ajh.24466","article-title":"Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients","volume":"91","author":"Antic","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0235","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamacardio.2018.4537","article-title":"Cardiovascular risk factors associated with venous thromboembolism","volume":"4","author":"Gregson","year":"2019","journal-title":"JAMA Cardiol."},{"issue":"8","key":"10.1016\/j.thromres.2025.109287_bb0240","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1055\/s-0031-1297369","article-title":"Obesity and venous thrombosis: a review","volume":"37","author":"Allman-Farinelli","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"issue":"9","key":"10.1016\/j.thromres.2025.109287_bb0245","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/jth.13388","article-title":"Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis","volume":"14","author":"Neshat-Vahid","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2025.109287_bb0250","article-title":"The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question","volume":"68","author":"O\u2019Brien","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"issue":"22","key":"10.1016\/j.thromres.2025.109287_bb0255","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.thromres.2025.109287_bb0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11239-015-1313-4","article-title":"Guidance for the prevention and treatment of cancer-associated venous thromboembolism","volume":"41","author":"Khorana","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"issue":"10","key":"10.1016\/j.thromres.2025.109287_bb0265","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0270","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00000658-198808000-00016","article-title":"Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis","volume":"208","author":"Clagett","year":"1988","journal-title":"Ann. Surg."},{"key":"10.1016\/j.thromres.2025.109287_bb0275","article-title":"Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines","volume":"22 Suppl 6","author":"Mandal\u00e0","year":"2011","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0280","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","article-title":"Upper extremity deep venous thrombosis in cancer patients with venous access devices--prophylaxis with a low molecular weight heparin (Fragmin)","volume":"75","author":"Monreal","year":"1996","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2025.109287_bb0285","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial","volume":"112","author":"Bern","year":"1990","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.thromres.2025.109287_bb0290","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1445-5994.2002.d01-28.x","article-title":"Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis","volume":"32","author":"Heaton","year":"2002","journal-title":"Intern. Med. J."},{"issue":"18","key":"10.1016\/j.thromres.2025.109287_bb0295","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1200\/JCO.2005.10.192","article-title":"Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer","volume":"23","author":"Couban","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.thromres.2025.109287_bb0300","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","article-title":"Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients","volume":"23","author":"Verso","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109287_bb0305","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents","volume":"104","author":"Greiner","year":"2019","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.thromres.2025.109287_bb0310","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109287_bb0315","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1055\/s-0040-1720975","article-title":"Bleeding with apixaban and dalteparin in patients with cancer-associated venous thromboembolism: results from the Caravaggio Study","volume":"121","author":"Ageno","year":"2021","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109287_bb0320","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2025.109287_bb0325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.001","article-title":"Venous and arterial thromboembolism in patients with cancer: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Gervaso","year":"2021","journal-title":"JACC CardioOncol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109287_bb0330","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol."},{"issue":"22","key":"10.1016\/j.thromres.2025.109287_bb0335","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.021765","article-title":"Thromboprophylaxis for children post-Fontan procedure: insights from the UNIVERSE study","volume":"10","author":"McCrindle","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.thromres.2025.109287_bb0340","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1055\/s-0039-1679938","article-title":"PREVAPIX-ALL: apixaban compared to standard of care for prevention of venous thrombosis in paediatric acute lymphoblastic leukaemia (ALL)-rationale and design","volume":"119","author":"O\u2019Brien","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109287_bb0345","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2352-3026(23)00314-9","article-title":"Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial","volume":"11","author":"O\u2019Brien","year":"2024","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2025.109287_bb0350","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2019.08.002","article-title":"A multi-national trial of a direct oral anticoagulant in children with cardiac disease: design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study","volume":"217","author":"Payne","year":"2019","journal-title":"Am. Heart J."},{"issue":"24","key":"10.1016\/j.thromres.2025.109287_bb0355","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2022.09.031","article-title":"Edoxaban for thromboembolism prevention in pediatric patients with cardiac disease","volume":"80","author":"Portman","year":"2022","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:19:03Z","timestamp":1774415943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":69,"alternative-id":["S0049384825000362"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109287","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous thromboembolism in children with Hodgkin lymphoma \u2013 A population-based study in Sweden, Finland, and Denmark","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109287"}}